Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Bloomberg Customers

February 10, 2016 6:49 AM ET


Company Overview of Alexion Pharmaceuticals, Inc.

Key Executives for Alexion Pharmaceuticals, Inc.

NameBoard RelationshipsTitleAge
David L. Hallal 10 RelationshipsChief Executive Officer and Director49
Leonard Bell M.D.10 RelationshipsCo-Founder, Chairman and Consultant57
Vikas Sinha M.B.A., C.A., CPANo RelationshipsChief Financial Officer and Executive Vice President52
Clare Carmichael No RelationshipsChief Human Resources Officer and Executive Vice President55
Michael V. Greco 1 RelationshipsVice President of Law, Corporate Secretary and Associate General Counsel--
View More Key Executives

Alexion Pharmaceuticals, Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Leonard Bell M.D. 10 RelationshipsAlexion Pharmaceuticals, Inc.57
David L. Hallal 10 RelationshipsAlexion Pharmaceuticals, Inc.49
Rockford Douglas Norby 42 RelationshipsMagnaChip Semiconductor Corporation79
Alvin S. Parven 10 RelationshipsAlexion Pharmaceuticals, Inc.75
Andreas Rummelt Ph.D. 29 RelationshipsInterPharmaLink AG59
View All Board Members

Alexion Pharmaceuticals, Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
Audit Committee Rockford Douglas Norby42 Relationships4 Executives
Compensation Committee Alvin S. Parven10 Relationships3 Executives
Nominating Committee J.D.Ann M. Veneman52 Relationships4 Executives
Corporate Governance Committee J.D.Ann M. Veneman52 Relationships4 Executives
Finance Committee Rockford Douglas Norby42 Relationships4 Executives
View Committee Details
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


  Industry Range
Not meaningful
Total Short Term Compensation$48.2M
Not meaningful
Total Value of Options$696.1K
Compensation as of Fiscal Year 2014
Alexion Pharmaceuticals, Inc. CEO Compensation
Industry Average


Wausau Paper Corp. Announces Management Changes
January 22, 2016 8:10 PM ET
Spectrum Brands Holdings, Inc. Appoints David M. Maura as Executive Chairman
January 21, 2016 11:30 AM ET
Peter Harf Intends to Step Down from the Board of Reckitt Benckiser Group plc
December 21, 2015 7:00 AM ET
Blue Power Group Limited Appoints Catherine K. Goodall as Director to the Board
December 05, 2015 12:00 AM ET
Procter & Gamble Co. Announces Executive Changes
November 20, 2015 11:57 PM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Alexion Pharmaceuticals, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at